FdaApplication
BLA 761164
Identifiers
- fda_app_no: BLA761164
Properties
| Property | Value |
|---|---|
| applicant_name | Recordati Rare Diseases, Inc. |
| application_type | BLA |
| approval_date | 2022-02-04 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ENJAYMO | SUTIMLIMAB-JOME | 1,100MG/22ML (50MG/ML) | Injection |
1 product